GDT Ontario Health Testing Eligibility
HCT v3
GTD Indications
Diagnosis
Carrier / Cascade Testing
GTD Samples Accepted
Blood
DNA
GTD Test Methodology
Sequencing
GTD Methodology Notes
Targeted Sanger sequencing for 3 BRCA1/BRCA2 pathogenic founder variants
Generic Test name (cms title)
Ashkenazi Jewish Panel
GTD Test type
Targeted Variant
GTD Location
Children's Hospital of Eastern Ontario
GTD Gene/Platform/Region List
BRCA1 (c.5266dupC), BRCA1 (c.68_69delAG), BRCA2 (c.5946delT)
GTD Category
Cancer
GTD Disease/Condition
Hereditary Breast Cancer (Ashkenazi Jewish mutations)